Duncker Streett & Co’s Allergan Inc AGN Stock Holding History

Duncker Streett & Co’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-8,075	Closed	-$1.72M	–	639
2014 Q4	$1.72M	Buy	8,075 +500	+7%	+$99.4K	0.56%	48
2014 Q3	$1.35M	Sell	7,575 -2,400	-24%	-$399K	0.46%	65
2014 Q2	$1.69M	Sell	9,975 -585	-6%	-$91.1K	0.55%	48
2014 Q1	$1.31M	Buy	10,560 +100	+1%	+$12.2K	0.46%	58
2013 Q4	$1.16M	Buy	10,460 +75	+0.7%	+$7.16K	0.42%	67
2013 Q3	$939K	Sell	10,385 -2,000	-16%	-$180K	0.38%	78
2013 Q2	$1.04M	Buy	+12,385	New	+$1.28M	0.4%	78

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Duncker Streett & Co's AGN Position: Q1 2015 in Review

Duncker Streett & Co sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 8,075 shares — an estimated $1.72M sold.

Duncker Streett & Co first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.72M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Duncker Streett & Co reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Duncker Streett & Co sold 8,075 Allergan Inc shares in Q1 2015, an estimated $1.72M.
Duncker Streett & Co first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Duncker Streett & Co's Allergan Inc position peaked at $1.72M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Duncker Streett & Co's 13F filing for Q1 2015, filed 28 Apr 2015.